The GC genotype of the MBL2 gene rs11003125 appears to be a protective factor in dengue infection in Burkina Faso

Lassina TRAORE, Mahamadi TIENDREBEOGO, Tegwindé Rébéca COMPAORE, Jean Claude Romaric Pingdwindé OUEDRAOGO, Mousso SAVADOGO, Teega-Wendé Clarisse OUEDRAOGO, Rogomenoma Alice OUEDRAOGO, Aristide Aziz Sidi TAPSOBA, Aminata Marie Simone Amsalet TRAORE, Wendyam Marie Christelle NADEMBEGA, Djénéba OUERMI, P Denise ILBOUDO, Florencia W DJIGMA, Jacques SIMPORE

Prevalence and Antibiotic Resistance of Urinary Tract Pathogens, with Molecular Identification of Klebsiella pneumoniae, Klebsiella oxytoca, and Acinetobacter spp., Using Multiplex Real-Time PCR.

TARNAGDA H., OUERMI D., SAGNA T., NADEMBEGA W.M.C., OUATTARA A.K., TRAORE L., OUEDRAOGO R.A., BADO P., BAZIE B.V. E.J.T., BOUDA/ZONGO N., ZONGO L., YONLI A.T., ZOHONCON T.M., DJIGMA F.W., SIMPORE J.

Rotavirus, Norovirus and Astrovirus in Children Aged 0 - 5 Years: Evolution of Prevalence over 10 Years (2013-2023) Following the Introduction of Rotavirus Vaccines in Burkina Faso.

DAKOUO D, OUATTARA A K, OUERMI D, TRAORE M A E, ZOHONCON T M, SAWADOGO M, ZIGANI N L, TAO N I, TRAORE L, OUEDRAOGO T-W C, OUEDRAOGO R A, KANDE A, GAMSONRE Z, BADO P, ILBOUDO P D, YONLI A T, DJIGMA F W, SIMPORE J

State of the HIV, Hepatitis B and C Virus Pandemic from 2003 to 2022 in Burkina Faso: Evolution of Prevalence Trends and Strategic Recommendations to Achieve the WHO’s Goal for Their Eradication by 2030.

ZOURE A.A., NADEMBEGA C., OUERMI D., OUATTARA A.K., TRAORE L., TIEMTORE A., SAWADOGO O., ZOHONCON T.M., DJIGMA F.W., SIMPORE J. and CERBA-LABIOGENE GROUP

Molecular Characterization of the Four Serotypes (DENV-1, DENV-2, DENV-3 and DENV-4) of Dengue Virus Circulating in Ouagadougou, Burkina Faso

Shoukrat Ohuwa Toyin Bello, Aziz Sidi Aristide Tapsoba, Abdou Azaque Zoure, Yidia Jean Romaric Bassole, Wend-La-Sida Ké, Prosper Bado, Olawoumi Fabrice Kouta, Fadilatou Tassembedo, Florencia Wendkuuni Djigma, Abdoulaye Diabate, Jacques Simpore